[文献资料]参 考 文 献

A phase ll study of new combination regimen with trastuzumab，and CDDP in HER2-positive advanced gastric cancer（HERBIS-1）. J Clin Oncol 31，2013（suppl。Abstr LBA4001）.Combined with FOLFOX for first-line therapy of patients（pts）with advanced gastric and gastr ......